The Recall Desk
CriticalFDA (Drugs)·D-0869-2016·Announced 2016-06-01

Avastin Syringes Recalled for Bacterial Contamination

AmEx Pharmacy is recalling 45 Avastin syringes nationwide because testing revealed bacterial contamination.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The recall is classified as FDA Class I, which meets the criteria for a Critical severity score.

Plain-English summary

Pacifico National, Inc. dba AmEx Pharmacy is recalling 45 syringes of Avastin (Bevacizumab) 2 mg/0.08 mL. The product is designated for office administration only and was distributed nationwide.

The recall was initiated because the product tested positive for bacterial contamination, indicating a lack of sterility. The affected lots are 141224C (expiring 03/24/2015) and 150915B (expiring 12/14/2015).

Patients who received this medication should contact their healthcare provider for further instructions. The recall is classified as Class I by the FDA.

The recalled product

Product
Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.
Affected units
45

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot #: 141224C
  • Exp. 03/24/2015
  • 150915B
  • Exp. 12/14/2015

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Pacifico National, Inc. dba AmEx Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Same manufacturer · Pacifico National, Inc. dba AmEx Pharmacy

See all →